Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
46 巻, 19 号
選択された号の論文の11件中1~11を表示しています
ORIGINAL ARTICLES
  • Tomoyuki Iwasaki, Masato Yoneda, Atsushi Nakajima, Yasuo Terauchi
    2007 年 46 巻 19 号 p. 1633-1639
    発行日: 2007年
    公開日: 2007/10/01
    ジャーナル オープンアクセス
    Objective We investigated the association between the serum butyrylcholinesterase (BChE) activity and parameters of adiposity, insulin resistance and the serum lipid profile, including the serum levels of triglyceride (TG), HDL-cholesterol (HDL-C) and LDL-cholesterol (LDL-C) in Japanese patients with type 2 diabetes and non-diabetic subjects.
    Patients and Methods A total of 259 Japanese subjects [171 patients with type 2 diabetes (age 60.4±11.9 years, BMI 25.0±4.4) and 88 non-diabetic subjects (age 54.2±15.0 years, BMI 25.8±4.7)] were enrolled in the study. To assess the hepatic fat content, the ratio of the CT attenuation value of the liver to that of the spleen (L/S ratio) was calculated.
    Results Serum BChE activity was significantly correlated with various indices of adiposity, including the waist circumference, L/S ratio, visceral fat area (VFA), subcutaneous fat area (SFA) and BMI, and also with the TG, HDL-C, LDL-C and HOMA-R, in the entire subject population. Even after adjustment for five variables, namely, age, gender, HbA1c, CRP and serum ferritin (the serum levels of ferritin and CRP have been reported to be associated with adiposity and insulin resistance), the serum BChE activity was still correlated with the waist circumference, L/S ratio, VFA, SFA, BMI, TG, HDL-C, LDL-C and HOMA-R. Furthermore, changes in the serum BChE activity were associated with changes in the L/S ratio, VFA and SFA at 1 year after the baseline.
    Conclusions These results indicate that the serum BChE activity is associated with parameters of adiposity, the serum lipid profile and the degree of insulin resistance.
  • Moritsugu Kimura, Masao Toyoda, Keiko Kobayashi, Makiko Abe, Takako Ko ...
    2007 年 46 巻 19 号 p. 1641-1645
    発行日: 2007年
    公開日: 2007/10/01
    ジャーナル オープンアクセス
    Objective Membranous nephropathy (MN) is the most common cause of adult-onset nephrotic syndrome and its management is still controversial. The aim of this study was to determine the effectiveness of corticosteroid-alone therapy for controlling proteinuria in MN.
    Methods Twenty-three patients, which had moderate proteinuria (admission 24-hour urinary protein excretion 1.0 to 3.5 g/day) with primary MN were studied retrospectively.
    Results Thirteen patients received corticosteroid-alone therapy combined with rest and dietary therapy (steroid group), while the other 10 patients were treated with rest and diet alone (non-steroid group). These two groups did not differ with respect to their laboratory features at the time of admission. After discharge, 5 of 13 patients of the steroid group dropped out . Therefore, only 8 patients could be followed up. As the result, 5 of 8 patients (62.5%) achieved complete remission (CR) and 3 of 8 patients (37.5%) had incomplete remission (ICR), so none of the patients failed to improve. On the other hand, 3 of 10 patients of the non-steroid group dropped out. Then, 7 patients were followed up. None of the 7 patients showed improvement during follow-up and 5 of these 7 patients were started on corticosteroids. Finally, as this result, 4 of 5 patients (80%) could achieve CR by 2 years after hospital discharge. Moreover, in the remaining 2 patients from the non-steroid group, no remission could be achieved even 2 years after discharge.
    Conclusion These results suggest that long-term corticosteroid-alone therapy is beneficial for controlling proteinuria in patients with MN.
CASE REPORTS
SHORT COMMUNICATIONS
PICTURES IN CLINICAL MEDICINES
feedback
Top